Brief: Aptose Biosciences Inc - QTRLY Loss Per Share $0.11
Aptose Biosciences Inc APS.TO :
* APTOSE REPORTS RESULTS FOR THE SECOND QUARTER 2022
* APTOSE BIOSCIENCES INC - QTRLY LOSS PER SHARE $0.11
Source text for Eikon: ID:nGNX79jDnk
Further company coverage: APS.TO
Recent news on Aptose Biosciences
See all newsBrief: Aptose Biosciences Says Closing Of Arrangement With Hanmi Pharmaceutical Further Delayed
Brief: Aptose Reports First Quarter 2026 Results
Brief: Leading Independent Proxy Advisory Firm Glass Lewis Endorses Aptose Plan Of Arrangement
Brief: Leading Independent Proxy Advisory Firm Iss Recommends Aptose Biosciences Shareholders Vote “For” Proposed Plan Of Arrangement With Hanmi Pharmaceutical
Brief: Aptose Biosciences Announces Amendment To Arrangement Agreement And Details Of Shareholders Meeting